Many studies have shown that Bcl-2 protein is overexpressed in many malignant drug-resistant tumor cells, as the protector of tumor cells against chemotherapy and the overexpression of Bcl-2 confer the pro-oncogenic function through apoptosis inhibition [20,21]. Here, BCL2 is linked to neoplasm.